Lucy Lu
Equibles does not estimate personal net worth.
Get an email with a short summary when Avenue Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get ATXI alertsAbout Lucy Lu
Lucy Lu is recorded as CFO at Avenue Therapeutics, Inc. (ATXI) since January 7, 2022. The proxy statement of Avenue Therapeutics, Inc. reports total compensation of $570,859 for Lucy Lu in fiscal 2022, including a base salary of $158,659. Disclosed compensation is on record for 5 fiscal years. Avenue Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Avenue Therapeutics, Inc. includes Alexandra MacLean (CEO and Board Member), Alexandra MacLean, M.D. (CEO and Board Member), Jay Kranzler, M.D., Ph.D. (Chairman and Board Member) and 7 others.
Affiliation history
-
Current
2022-01-07–present
-
2015-01-01–2022-03-31
-
Start not stated–2022-03-31
Company network
Leadership on record at Avenue Therapeutics, Inc.
- Alexandra MacLean CEO, Board Member
- Alexandra MacLean, M.D. CEO, Board Member
- Jay Kranzler, M.D., Ph.D. Chairman, Board Member
- David Jin CFO
- Curtis Oltmans Board Member
- Faith Charles Board Member
- Faith L. Charles Board Member
- Jay Kranzler Board Member
- Lindsay A. Rosenwald Board Member
- Lindsay A. Rosenwald, M.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Avenue Therapeutics, Inc. (ATXI) | Former Chief Executive Officer | $158,659 | $570,859 |
| 2021 | Avenue Therapeutics, Inc. (ATXI) | Former Chief Executive Officer | $454,647 | $1,082,128 |
| 2020 | Avenue Therapeutics, Inc. (ATXI) | Chief Executive Officer | $431,627 | $443,027 |
| 2019 | Avenue Therapeutics, Inc. (ATXI) | Chief Executive Officer | $419,055 | $639,783 |
| 2018 | Avenue Therapeutics, Inc. (ATXI) | Chief Executive Officer | $406,850 | $1,594,633 |
Recent activity
No call appearances or filed executive changes recorded yet.